← back to search

Fabien Subtil

Hôpital Edouard Herriot · FR
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Gastric Cancer Management and Outcomes, Colorectal Cancer Screening and Detection, Gastrointestinal Tumor Research and Treatment, and Pancreatic and Hepatic Oncology Research.
h-index
28
citations
3,702
works
212
NIH funding
primary concept
Medicine
email

Recent publications

Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study
Diabetes Care 2025cited by 25position: middledoi
Arterial Collaterals and Endovascular Treatment Effect in Acute Ischemic Stroke with Large Infarct: A Secondary Analysis of the TENSION Trial
Radiology 2025cited by 20position: middledoi
Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial
The Lancet Neurology 2024cited by 62position: middledoi
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial
Lung Cancer 2024cited by 18position: middledoi
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
The Lancet 2023cited by 421position: middledoi
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
European Journal of Cancer 2023cited by 28position: middledoi
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018
European Journal of Cancer 2023cited by 24position: middledoi
Use of endoscopic submucosal dissection or full-thickness resection device to treat residual colorectal neoplasia after endoscopic resection: a multicenter historical cohort study
Endoscopy 2023cited by 17position: middledoi
Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors
The American Journal of Gastroenterology 2023cited by 17position: middledoi
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4
Communications Biology 2022cited by 65position: middledoi
Effects of opioid-free anesthesia on postoperative morphine consumption after bariatric surgery
Journal of Clinical Anesthesia 2022cited by 28position: middledoi
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study
Surgery 2022cited by 23position: middledoi
Endoscopic characterization of colorectal neoplasia with different published classifications: comparative study involving CONECCT classification
Endoscopy International Open 2022cited by 19position: middledoi
Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion
Endoscopy 2022cited by 15position: middledoi
Prevalence of obesity among adult inpatients with COVID-19 in France
The Lancet Diabetes & Endocrinology 2020cited by 342position: middledoi
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease
Arthritis & Rheumatology 2020cited by 56position: middledoi
First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study
American Journal of Hematology 2020cited by 50position: middledoi
Age- and Sex-Specific TSH Upper-Limit Reference Intervals in the General French Population: There Is a Need to Adjust Our Actual Practices
Journal of Clinical Medicine 2020cited by 43position: middledoi
Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection
Endoscopy 2020cited by 34position: middledoi
Early Detection of Patients at Risk of Developing a Post-Traumatic Stress Disorder After an ICU Stay*
Critical Care Medicine 2020cited by 20position: middledoi
Results of in vitro fertilization versus intrauterine insemination in patients with low anti-Müllerian hormone levels. A single-center retrospective study of 639 + 119 cycles
Journal of Gynecology Obstetrics and Human Reproduction 2020cited by 17position: middledoi
Multicenter Evaluation of Clinical Efficacy and Safety of Per‐oral Endoscopic Myotomy in Children
Journal of Pediatric Gastroenterology and Nutrition 2019cited by 47position: middledoi
Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study
The Lancet Infectious Diseases 2019cited by 46position: middledoi
Botulinum toxin for the treatment of hypercontractile esophagus: Results of a double‐blind randomized sham‐controlled study
Neurogastroenterology & Motility 2019cited by 36position: middledoi
A simplified table using validated diagnostic criteria is effective to improve characterization of colorectal polyps: the CONECCT teaching program
Endoscopy International Open 2019cited by 29position: middledoi
Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life
Blood 2018cited by 21position: middledoi
kmlShape: An Efficient Method to Cluster Longitudinal Data (Time-Series) According to Their Shapes
PLoS ONE 2016cited by 110position: lastdoi
The precision–recall curve overcame the optimism of the receiver operating characteristic curve in rare diseases
Journal of Clinical Epidemiology 2015cited by 421position: middledoi
Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality
BMC Medical Research Methodology 2015cited by 67position: middledoi
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
The Lancet Oncology 2014cited by 283position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mathieu Pioche · IRCCS Humanitas Research Hospital5 papers (2019–2022)Jérémie Jacques · Centre Hospitalier Universitaire de Limoges4 papers (2019–2022)Vincent Lépilliez · Hôpital Privé Jean Mermo4 papers (2019–2022)Jérôme Rivory · Hospices Civils de Lyon4 papers (2019–2022)René Écochard · Université Claude Bernard Lyon 13 papers (2012–2016)Jean‐Christophe Saurin · Hospices Civils de Lyon3 papers (2019–2022)Côme Lepage · Université Claude Bernard Lyon 13 papers (2014–2019)Thierry Ponchon · Université Claude Bernard Lyon 13 papers (2019–2022)Laurent Greillier · Centre de Recherche en Cancérologie de Marseille2 papers (2023–2024) · 2 papers (2020–2025)Thomas Rimmelé · Université Claude Bernard Lyon 12 papers (2020–2022)Florian Guisier · Hôpital Charles-Nicolle2 papers (2023–2024)Timothée Wallenhorst · Nutrition, métabolismes et cancer2 papers (2020–2022)Sarah Leblanc · Hôpital Privé Jean Mermo2 papers (2022–2022)Romain Legros · Université de Rouen Normandie2 papers (2022–2022) · 2 papers (2019–2022) · 2 papers (2015–2016)Valérie Hervieu · Centre Hospitalier Le Vinatier2 papers (2022–2025)Jean‐Baptiste Chevaux · Centre Hospitalier Régional et Universitaire de Nancy2 papers (2022–2022)Xavier Dray · Novartis (Switzerland)2 papers (2019–2022)